Tech Company Financing Transactions

Invitae Funding Round

Invitae, based in San Francisco, raised $120 million from Casdin Capital, Decheng Capital and Deerfield Capital.

Transaction Overview

Company Name
Announced On
10/13/2014
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Series F
Proceeds Purpose
Invitae plans to use the proceeds to accelerate the build out of its infrastructure for its genetic information business, as well as to expand its global presence.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1400 16th St.
San Francisco, CA 94103
USA
Email Address
Overview
Invitae Corporation (NYSE: NVTA), a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally.
Profile
Invitae LinkedIn Company Profile
Social Media
Invitae Company Twitter Account
Company News
Invitae News
Facebook
Invitae on Facebook
YouTube
Invitae on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Randy Scott
  Randy Scott LinkedIn Profile  Randy Scott Twitter Account  Randy Scott News  Randy Scott on Facebook
Chief Marketing Officer
Robert Nussbaum
  Robert Nussbaum LinkedIn Profile  Robert Nussbaum Twitter Account  Robert Nussbaum News  Robert Nussbaum on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/13/2014: ParLevel venture capital transaction
Next: 10/13/2014: GoGoGab venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document funding rounds that are announced publicly. VC transactions on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary